GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » Price-to-Operating-Cash-Flow

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Price-to-Operating-Cash-Flow : 42.88 (As of May. 17, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi Price-to-Operating-Cash-Flow?

As of today (2024-05-17), Laboratorios Farmaceuticos Rovi's share price is €85.75. Laboratorios Farmaceuticos Rovi's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €2.00. Hence, Laboratorios Farmaceuticos Rovi's Price-to-Operating-Cash-Flow Ratio for today is 42.88.

The historical rank and industry rank for Laboratorios Farmaceuticos Rovi's Price-to-Operating-Cash-Flow or its related term are showing as below:

XMAD:ROVI' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.09   Med: 24.23   Max: 602.94
Current: 42.88

During the past 13 years, Laboratorios Farmaceuticos Rovi's highest Price-to-Operating-Cash-Flow Ratio was 602.94. The lowest was 8.09. And the median was 24.23.

XMAD:ROVI's Price-to-Operating-Cash-Flow is ranked worse than
65.75% of 292 companies
in the Biotechnology industry
Industry Median: 26.395 vs XMAD:ROVI: 42.88

Laboratorios Farmaceuticos Rovi's Cash Flow from Operations per share for the three months ended in Dec. 2023 was €1.18. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €2.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Laboratorios Farmaceuticos Rovi was -52.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 36.00% per year.

During the past 13 years, Laboratorios Farmaceuticos Rovi's highest 3-Year average Operating Cash Flow per Share Growth Rate was 164.60% per year. The lowest was -34.50% per year. And the median was 15.50% per year.


Laboratorios Farmaceuticos Rovi Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi Price-to-Operating-Cash-Flow Chart

Laboratorios Farmaceuticos Rovi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 44.80 27.36 8.11 28.28

Laboratorios Farmaceuticos Rovi Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.85 18.45 22.55 28.28 -

Competitive Comparison of Laboratorios Farmaceuticos Rovi's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Laboratorios Farmaceuticos Rovi's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorios Farmaceuticos Rovi's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Price-to-Operating-Cash-Flow falls into.



Laboratorios Farmaceuticos Rovi Price-to-Operating-Cash-Flow Calculation

Laboratorios Farmaceuticos Rovi's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=85.75/2
=42.88

Laboratorios Farmaceuticos Rovi's Share Price of today is €85.75.
Laboratorios Farmaceuticos Rovi's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Laboratorios Farmaceuticos Rovi Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Traded in Other Exchanges
Address
Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Headlines